Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
CAH Stock Forecast 2025-2026
$137.56
Current Price
$33.23B
Market Cap
Buy 11
Hold 5
Sell 1
Wall St Analyst Ratings
Distance to CAH Price Targets
+13.4%
To High Target of $156.00
+9.0%
To Median Target of $150.00
-15.7%
To Low Target of $116.00
CAH Price Momentum
+4.9%
1 Week Change
+0.8%
1 Month Change
+33.3%
1 Year Change
+16.3%
Year-to-Date Change
-1.4%
From 52W High of $139.50
+47.6%
From 52W Low of $93.17
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Cardinal Health (CAH) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on CAH and similar high-potential opportunities.
Latest CAH Stock Price Targets & Analyst Predictions
Based on our analysis of 23 Wall Street analysts, CAH has a bullish consensus with a median price target of $150.00 (ranging from $116.00 to $156.00). The overall analyst rating is Strong Buy (8.2/10). Currently trading at $137.56, the median forecast implies a 9.0% upside. This outlook is supported by 11 Buy, 5 Hold, and 1 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CAH Analyst Ratings
11
Buy
5
Hold
1
Sell
CAH Price Target Range
Low
$116.00
Average
$150.00
High
$156.00
Current: $137.56
Latest CAH Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CAH.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 11, 2025 | B of A Securities | Michael Cherny | Buy | Maintains | $155.00 |
| Mar 31, 2025 | Mizuho | Steven Valiquette | Outperform | Maintains | $150.00 |
| Feb 5, 2025 | Jefferies | Brian Tanquilut | Buy | Upgrade | $150.00 |
| Feb 4, 2025 | Wells Fargo | Stephen Baxter | Equal-Weight | Maintains | $136.00 |
| Feb 4, 2025 | JP Morgan | Lisa Gill | Neutral | Maintains | $145.00 |
| Jan 31, 2025 | Morgan Stanley | Erin Wright | Overweight | Maintains | $142.00 |
| Jan 29, 2025 | Wells Fargo | Stephen Baxter | Equal-Weight | Maintains | $135.00 |
| Jan 24, 2025 | JP Morgan | Lisa Gill | Neutral | Maintains | $142.00 |
| Jan 10, 2025 | Citigroup | Daniel Grosslight | Neutral | Maintains | $129.00 |
| Jan 8, 2025 | TD Cowen | Charles Rhyee | Buy | Upgrade | $144.00 |
| Jan 7, 2025 | Evercore ISI Group | Elizabeth Anderson | Outperform | Upgrade | $140.00 |
| Jan 6, 2025 | B of A Securities | Michael Cherny | Buy | Upgrade | $145.00 |
| Dec 17, 2024 | Morgan Stanley | Erin Wright | Overweight | Maintains | $136.00 |
| Dec 13, 2024 | Wells Fargo | Stephen Baxter | Equal-Weight | Upgrade | $127.00 |
| Nov 4, 2024 | Barclays | Stephanie Davis | Overweight | Maintains | $133.00 |
| Nov 4, 2024 | Mizuho | Ann Hynes | Neutral | Maintains | $120.00 |
| Nov 4, 2024 | Deutsche Bank | George Hill | Hold | Maintains | $124.00 |
| Nov 4, 2024 | UBS | Kevin Caliendo | Buy | Maintains | $139.00 |
| Nov 4, 2024 | Morgan Stanley | Erin Wright | Overweight | Maintains | $127.00 |
| Oct 22, 2024 | UBS | Kevin Caliendo | Buy | Maintains | $134.00 |
Cardinal Health Inc. (CAH) Competitors
The following stocks are similar to Cardinal Health based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
CAH
Cardinal Health
mkt cap
33.23B
Cardinal Health Inc. (CAH) Financial Data
Cardinal Health Inc. has a market capitalization of $33.23B with a P/E ratio of 25.7x. The company generates $222.28B in trailing twelve-month revenue with a 0.6% profit margin.
Revenue growth is -3.8% quarter-over-quarter, while maintaining an operating margin of +1.0% and return on equity of -26.5%.
Valuation Metrics
Market Cap
$33.23B
Enterprise Value
$36.90B
P/E Ratio
25.7x
PEG Ratio
15.9x
Price/Sales
0.1x
Growth & Margins
Revenue Growth (YoY)
-3.8%
Gross Margin
+3.5%
Operating Margin
+1.0%
Net Margin
+0.6%
EPS Growth
+8.7%
Financial Health
Cash/Price Ratio
+12.1%
Current Ratio
1.0x
Debt/Equity
-2.6x
ROE
-26.5%
ROA
+3.0%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Cardinal Health Inc. (CAH) Business Model
About Cardinal Health Inc.
What They Do
Provides comprehensive healthcare solutions and products.
Business Model
The company operates primarily through healthcare distribution and supply chain management, serving hospitals, pharmacies, and healthcare providers. It generates revenue by distributing pharmaceuticals, medical products, and laboratory supplies, along with offering services such as inventory management and logistics optimization.
Additional Information
Based in Dublin, Ohio, Cardinal Health is one of the largest pharmaceutical distributors in the U.S., playing a crucial role in ensuring the availability of essential drugs and medical supplies globally, and significantly contributing to the healthcare infrastructure.
Company Information
Sector
Healthcare
Industry
Medical Distribution
Employees
47,922
CEO
Mr. Jason M. Hollar
Country
United States
IPO Year
1987
Website
www.cardinalhealth.comCardinal Health Inc. (CAH) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Cardinal Health (CAH) Rises Yet Lags Behind Market: Some Facts Worth Knowing
Cardinal Health (CAH) closed the most recent trading day at $133.69, moving +1.92% from the previous trading session.
Apr 22, 2025
By Zacks Equity Research
Tale of the Tape
Danaher Gears Up to Post Q1 Earnings: Is a Beat in Store?
DHR's first-quarter earnings are likely to have been aided by strength in the Biotechnology segment. However, weakness in the Diagnostics and Life Sciences segments are expected to have hurt.
Apr 21, 2025
By Zacks Equity Research
Analyst Blog
Latest News
Quick Summary
Cardinal Health (CAH) is expected to deliver a strong earnings report, supported by favorable conditions for an earnings beat.
Why It Matters
Cardinal's potential earnings beat may boost its stock price, indicating strong performance and investor confidence, impacting overall market sentiment and investment strategies.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Cardinal Health (CAH) closed at $133.69, up 1.92% from the prior trading session.
Why It Matters
A 1.92% increase in Cardinal Health's stock price indicates positive market sentiment, potentially attracting more investor interest and affecting overall market valuation.
Source: Zacks Investment Research
Market Sentiment:
Negative
Quick Summary
Cardinal Health (CAH) closed at $134.36, up 0.08% from the previous trading session.
Why It Matters
A slight price increase in Cardinal Health indicates stability and potential investor confidence, which can influence market perception and trading strategies.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Quick Summary
Four stocks in the Dental Supplies industry identified for potential investor wealth are CAH, MMSI, XRAY, and CNMD.
Why It Matters
The mention of four promising dental supply stocks indicates potential growth opportunities, signaling investors to consider these companies for portfolio diversification and profit potential.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Zacks Style Scores provide a method for investors to identify top-rated stocks tailored to their investing preferences.
Why It Matters
The Zacks Style Scores can help investors identify high-potential stocks tailored to their strategies, potentially enhancing portfolio performance and optimizing investment decisions.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Cardinal Health, Atmos Energy, and General Mills have been selected by an ESG fund manager for inclusion in their investment portfolio.
Why It Matters
Inclusion of Cardinal Health, Atmos Energy, and General Mills in an ESG fund signals strong sustainability practices, potentially attracting more investment and positively impacting stock performance.
Source: Barrons
Market Sentiment:
Positive
Frequently Asked Questions About CAH Stock
What is Cardinal Health Inc.'s (CAH) stock forecast for 2025?
Based on our analysis of 23 Wall Street analysts, Cardinal Health Inc. (CAH) has a median price target of $150.00. The highest price target is $156.00 and the lowest is $116.00.
Is CAH stock a good investment in 2025?
According to current analyst ratings, CAH has 11 Buy ratings, 5 Hold ratings, and 1 Sell ratings. The stock is currently trading at $137.56. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CAH stock?
Wall Street analysts predict CAH stock could reach $150.00 in the next 12 months. This represents a 9.0% increase from the current price of $137.56. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Cardinal Health Inc.'s business model?
The company operates primarily through healthcare distribution and supply chain management, serving hospitals, pharmacies, and healthcare providers. It generates revenue by distributing pharmaceuticals, medical products, and laboratory supplies, along with offering services such as inventory management and logistics optimization.
What is the highest forecasted price for CAH Cardinal Health Inc.?
The highest price target for CAH is $156.00 from at , which represents a 13.4% increase from the current price of $137.56.
What is the lowest forecasted price for CAH Cardinal Health Inc.?
The lowest price target for CAH is $116.00 from at , which represents a -15.7% decrease from the current price of $137.56.
What is the overall CAH consensus from analysts for Cardinal Health Inc.?
The overall analyst consensus for CAH is bullish. Out of 23 Wall Street analysts, 11 rate it as Buy, 5 as Hold, and 1 as Sell, with a median price target of $150.00.
How accurate are CAH stock price projections?
Stock price projections, including those for Cardinal Health Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 28, 2025 12:04 PM UTC